Literature DB >> 22218269

Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.

Catherine L Macphail1, Jennifer N Sayles, William Cunningham, Peter A Newman.   

Abstract

Concerns about the impact of risk compensation on advances in biomedical human immunodeficiency virus (HIV) prevention technologies have been documented. We conducted an exploratory qualitative study using focus group discussions with young South African men and women (aged 18 to 24 years) to explore perceptions of risk compensation with regard to a hypothetical posttrial HIV vaccine. During the discussions, participants expressed their disquiet about the potential for risk compensation and the manner in which this might manifest among young people. Discussions specifically focused on reductions in condom use, an increase in multiple partners, and increased frequency of sex. The discussions also revealed contradictory feelings about HIV vaccines: appreciation for their development tempered by concerns about loss of control and undermining morality. Women were particularly concerned with the possibility of increased partner concurrency and infidelity. We suggest that concerns in HIV vaccine target populations about the impact of possible risk compensation be incorporated into strategies for vaccine introduction once vaccines move from the hypothetical to reality.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218269      PMCID: PMC3735355          DOI: 10.1177/1049732311431944

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  48 in total

1.  Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand.

Authors:  Frits van Griensvan; Jaranit Keawkungwal; Jordan W Tappero; Udomsak Sangkum; Punnee Pitisuttithum; Suphak Vanichseni; Pravan Suntharasamai; Karin Orelind; Carolyn Gee; Kachit Choopanya
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

2.  Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Authors:  P Autier; J F Doré; M S Cattaruzza; F Renard; H Luther; F Gentiloni-Silverj; E Zantedeschi; M Mezzetti; I Monjaud; M Andry; J F Osborn; A R Grivegnée
Journal:  J Natl Cancer Inst       Date:  1998-12-16       Impact factor: 13.506

3.  Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations.

Authors:  S D Pinkerton
Journal:  Risk Anal       Date:  2001-08       Impact factor: 4.000

4.  Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.

Authors:  M A Chesney; D B Chambers; J O Kahn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-01

5.  Infrequent parental monitoring predicts sexually transmitted infections among low-income African American female adolescents.

Authors:  Richard A Crosby; Ralph J DiClemente; Gina M Wingood; Delia L Lang; Kathy Harrington
Journal:  Arch Pediatr Adolesc Med       Date:  2003-02

Review 6.  Advances in HIV treatment and prevention: should treatment optimism lead to prevention pessimism?

Authors:  F Lert
Journal:  AIDS Care       Date:  2000-12

7.  Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.

Authors:  Peter A Newman; Naihua Duan; Ellen T Rudy; Kathleen J Roberts; Dallas Swendeman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-11-01       Impact factor: 3.731

8.  Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Authors:  Jeffrey N Martin; Michelle E Roland; Torsten B Neilands; Melissa R Krone; Joshua D Bamberger; Robert P Kohn; Margaret A Chesney; Karena Franses; James O Kahn; Thomas J Coates; Mitchell H Katz
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

9.  Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.

Authors:  Nicole Crepaz; Trevor A Hart; Gary Marks
Journal:  JAMA       Date:  2004-07-14       Impact factor: 56.272

Review 10.  Shifts in condom use following microbicide introduction: should we be concerned?

Authors:  Anna M Foss; Peter T Vickerman; Lori Heise; Charlotte H Watts
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

View more
  13 in total

1.  Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination.

Authors:  April M Young; Daniel S Halgin; Jennifer R Havens
Journal:  AIDS Care       Date:  2015-03-02

2.  The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.

Authors:  Jonathan E Volk; Nancy A Hessol; Glenda E Gray; James G Kublin; Gavin J Churchyard; Koleka Mlisana; Maphoshane Nchabeleng; Susan P Buchbinder; Linda-Gail Bekker
Journal:  Int J STD AIDS       Date:  2013-10-08       Impact factor: 1.359

3.  Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.

Authors:  Lucy Chimoyi; Mphatso Kamndaya; Emilie Venables; Nina von Knorring; Jonathan Stadler; Catherine MacPhail; Matthew F Chersich; Helen Rees; Sinead Delany-Moretlwe
Journal:  BMC Public Health       Date:  2017-07-04       Impact factor: 3.295

4.  The future of a partially effective HIV vaccine: assessing limitations at the population level.

Authors:  Christian Selinger; Dobromir T Dimitrov; Philip A Welkhoff; Anna Bershteyn
Journal:  Int J Public Health       Date:  2019-04-13       Impact factor: 3.380

5.  Give PrEP a chance: moving on from the "risk compensation" concept.

Authors:  Daniela Rojas Castro; Rosemary M Delabre; Jean-Michel Molina
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

6.  Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensation.

Authors:  April M Young; Daniel S Halgin; Ralph J DiClemente; Claire E Sterk; Jennifer R Havens
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

7.  Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.

Authors:  Natasha Mack; Jacob Odhiambo; Christina M Wong; Kawango Agot
Journal:  BMC Health Serv Res       Date:  2014-05-21       Impact factor: 2.655

8.  Resilience, tipping, and hydra effects in public health: emergent collective behavior in two agent-based models.

Authors:  Christopher Robert Keane
Journal:  BMC Public Health       Date:  2016-03-15       Impact factor: 3.295

9.  Beyond Risk Compensation: Clusters of Antiretroviral Treatment (ART) Users in Sexual Networks Can Modify the Impact of ART on HIV Incidence.

Authors:  Wim Delva; Stéphane Helleringer
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

10.  'Why would you promote something that is less percent safer than a condom?': Perspectives on partially effective HIV prevention technologies among key populations in South Africa.

Authors:  Clara Rubincam; Peter A Newman; Millicent Atujuna; Linda-Gail Bekker
Journal:  SAHARA J       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.